Making Clinical Trial Safety and Pharmacovigilance easy and affordable with HALOPV

LINK Medical & Insife have created a partnership to offer easy and affordable clinical trial safety and pharmacovigilance solutions. In this webinar, you will learn how HALOPV, a sophisticated safety toolkit helps biotech and pharma companies manage their clinical trial safety and pharmacovigilance activities in a simple and cost-effective way. Modules are available to cover all data and processes. You can start with the safety database modules and slowly add to your suite of modules, until you have a full pharmacovigilance system. You will hear from Martin Holm-Petersen CEO of Insife and also from the International Safety Director Tina Elberling and Ewa Lyzell, Safety Group Manager for a full overview of how the concept of a database are transforming into a flexible model, now being a possible solution for all companies.

Speakers:

Tina Elberling

Safety Director
Tina holds both an MD and a Ph.D. from Copenhagen University and apart from residential and medical internship positions, she has conducted both pre-clinical and clinical research. within the field of cerebral blood flow auto-regulation and psychoneuroendocrinology. Ffurthermore, she has worked as a sub-investigator in clinical phase I-IV trials at the Danish Dementia Research Center. In addition, Tina has more than 15 years of experience within the pharmaceutical industry, mainly with clinical trial safety and pharmacovigilance, and have worked with some of the most known safety databases, including system ownership and responsible for upgrades. Prior to and a period as GVP inspector at the Danish Medicines Agency, before joining LINK Medical in August 2020, as head of International Safety Operations Tina worked as GVP inspector at the Danish Medicines Agency.

Ewa Lyzell

Safety Group Manager
Ewa is a registered nurse in Sweden and holds a BSc in Medical Science from the University in Lund. After a few years working within the radiation therapy field, she started working in the pharmaceutical industry holding various positions in the field of pharmacovigilance. Since then, she has worked with clinical trial safety and pharmacovigilance for more than 25 years. Ewa has international experience working for pharmaceutical companies in Sweden, Denmark and the US. In addition to her role as Group Manager for the Safety Operations team in Sweden, Ewa also holds the position of EU Qualified Person responsible for Pharmacovigilance (EU QPPV).

Martin Holm-Petersen

CEO, Insife
Executive leader with 10 years of experience within the pharma industry and another 10+ years in consulting. Martin is an experienced manager and strategist, with understanding across the pharma business value chain, and an expert on Pharmacovigilance. His current role is CEO of Insife, a global consulting and technology company. In this capacity, digital transformation is central to Martin’s engagements with Industry and Regulatory Agencies. In his previous role, he headed the pvtech global industry pharmacovigilance technology network with more than half of top 100 pharma participating.